4 September 2026 – C4X Discovery Holdings Ltd (“C4XD”), a pioneering Drug Discovery company, today announces that it will receive a $13 million milestone payment from AstraZeneca [LON: AZN], triggered by the entry of the oral NRF2 activator programme into the clinic. Under the terms of the licensing agreement announced in November 2022, C4XD is potentially eligible to receive up to $400 million in preclinical, clinical development and commercial milestones, and to tiered mid-single digit royalties on future sales. AstraZeneca is advancing AZD4916, an oral NRF2 activator from the programme licensed from C4XD, in a Phase I study in healthy volunteers. The programme is being developed for the treatment of inflammatory and respiratory diseases. Nick Ray, CSO of C4X Discovery, said: “We are delighted to see the NRF2 activator programme progressing...

The consolidated revenue of the companies operated by MAXIMA GRUPĖ, UAB in the Baltic States (hereinafter – the Group) increased by 2.8% year on year in the first half of 2026, reaching EUR 2.03 billion. Consolidated like-for-like retail revenue grew by 2.1%.  “The first half of 2026 stands out for MAXIMA retail chains reducing the regular prices of 9 thousand food products in Lithuania and 4 thousand in Latvia. This step strengthens our position as the low-price leader and enables customers to purchase products at lower prices every day without having to wait for special offers. This is a significant change for our business, partners and customers with established shopping habits,” emphasises Petras Jašinskas, Chief Financial Officer of MAXIMA GRUPĖ, UAB.  The Group’s revenue growth remained stable and exceeded food inflation in the Baltic...

Peter Schleidt retiresPeter Schleidt, COO and Member of the Group Executive Board, will retire at the end of September 2026. Peter Schleidt joined the Group Executive Board in 2017. Prior to that, he served as Group Executive Director and COO of TDC, and as Executive Vice President, CIO of Danske Bank. In addition, Peter Schleidt served on Jyske Bank’s Supervisory Board from 2016 to 2017. Kurt Bligaard Pedersen, Chairman of the Supervisory Board, states:”The Supervisory Board is grateful for the substantial and highly valuable contribution that Peter Schleidt has made to both operations and digitalisation at Jyske Bank over the past ten years.  During this period, important steps were taken in the development of digital solutions for the benefit of Jyske Bank’s customers and employees.” Klaus Naur new COO and member of the Group Executive...

EINDHOVEN, the Netherlands, Sept. 04, 2026 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury and other movement disabilities, today announced that it will release its first-half 2026 financial results and host a webcast with a comprehensive business update on September 9, 2026. The webcast, presented by CEO Dave Marver, will begin at 2:00 p.m. CEST / 8:00 a.m. EDT. To join, please register using this link. A replay of the webcast and supporting materials will be available at ir.onwd.com. About ONWARD Medical ONWARD Medical is the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI)...

BOCA RATON, Fla., Sept. 04, 2026 (GLOBE NEWSWIRE) — Invest Acquisition Corporation (OTC: IVCB, IVCBU, IVCBW) today announced it has filed a definitive information statement with the SEC extending the deadline to complete its initial business combination to December 17, 2029. An extraordinary general meeting will be held on September 24, 2026 in connection with the extension. Public shareholders have the right to redeem their Class A ordinary shares for a pro rata portion of the trust account; redemption requests must be submitted to the Company’s transfer agent by 5:00 p.m. Eastern Time on September 22, 2026. Full details are available in the Company’s information statement filed with the SEC at www.sec.gov. Forward Looking Statements This press release contains statements that constitute “forward-looking statements”...

THE WOODLANDS, Texas, Sept. 03, 2026 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) today announced it closed 409 homes in August 2026, including 9 currently or previously leased single-family rental homes. This represents a 9.9% increase compared to 372 homes closed in August 2025. As of August 31, 2026, the Company had 153 active selling communities. About LGI Homes, Inc. Headquartered in The Woodlands, Texas, LGI Homes, Inc. is a pioneer in the homebuilding industry, successfully applying an innovative and systematic approach to the design, construction and sale of homes across 36 markets in 21 states. LGI Homes has closed over 80,000 homes since its founding in 2003 and has delivered profitable financial results every year. Nationally recognized for its quality construction and exceptional customer service, LGI Homes was...

With its two platforms “micAuto” and “DynaPlanet”, Micware aims to evolve into a business where technology assets continuously create value KOBE, Japan, Sept. 03, 2026 (GLOBE NEWSWIRE) — Micware Co., Ltd. (Nasdaq: MWC) (the “Company” or “Micware”), a Japan-based provider of software development services and innovative IT solutions mainly focused on the automotive and mobility sectors, today announced the launch of a platform-based growth strategy designed to convert the technologies, data, and development expertise it has accumulated through in-vehicle software development into sustained value. By positioning mobility and digital spaces as new growth domains, Micware aims to evolve from a business centered on individual development projects into one that can deploy its technology assets more broadly. The two platforms supporting...

–4-year data from the Phase 1/2a open-label extension (OLE) studies showed substantial and durable reductions in seizures and continuing improvements in cognition and behavior in patients treated with zorevunersen on top of standard of care anti-seizure medicines– –New data showed substantial reductions in the most severe seizure types, the leading risk factor for sudden unexpected death in epilepsy (SUDEP)– –Improvements in quality of life were demonstrated through 28 months of treatment– –Zorevunersen generally well tolerated, with some patients treated for more than 5 years– –Data from the global, pivotal Phase 3 EMPEROR study anticipated in Q3 2027 to complete the planned rolling U.S. NDA submission to the FDA– BEDFORD, Mass. and CAMBRIDGE, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) — Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology...

MONTREAL, Sept. 03, 2026 (GLOBE NEWSWIRE) — Nordique Critical Metals Inc. (formerly, Consolidated Lithium Metals Inc.) (TSXV: NQC | FRA: Z36 | OTCQB: JORFF) (“NQC” or the “Company”) is pleased to report an update on its work programs required to acquire (the “Acquisition”) and exercise its option to earn an undivided interest of up to 80% in the Kwyjibo Rare Earth Project (the “Project”), subject to the satisfaction of certain conditions. Further to the Company’s press release dated August 12, 2026, NQC has submitted the Project’s preliminary economic assessment technical report (the “Report”) and corresponding financial plan to the TSX Venture Exchange (“TSXV”), the submissions of which are conditions to closing set out in the conditional approval letter of the TSXV. The Report was subsequently filed by the Company on its SEDAR+...

TORONTO, Sept. 03, 2026 (GLOBE NEWSWIRE) — Euro Sun Mining Inc. (TSX: ESM) (“Euro Sun” or the “Company”) is pleased to announce that it has entered into a non‑binding Memorandum of Understanding (“MoU”) dated September 3, 2026 with Macquarie Bank Limited (“Macquarie”) and Trafigura PTE LTD (“Trafigura”). Under the terms of the MoU, the parties will work together on a proposed senior project finance facility of up to US$400 million (the “Facility”) to support the development of the Company’s Rovina Valley Gold‑Copper Project in Romania. Under the MoU, Macquarie and Trafigura will work together during an 18‑month mandate period to conduct due diligence, develop a financing structure, and seek internal approvals required to deliver a commitment letter for arranging, syndicating and underwriting the Facility. While the MoU represents...